Alerts will be sent to your verified email
Verify EmailCOSCO
|
Cosco India
|
Novelix Pharma
|
Silkflex Polymers
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.41 % | -17.5 % | 15.96 % |
|
5yr average Equity Multiplier
|
6.32 | 1.26 | 2.7 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 0.84 | 1.43 |
|
5yr Avg Net Profit Margin
|
2.11 % | -14.11 % | 4.62 % |
|
Price to Book
|
1.94 | 5.25 | 2.7 |
|
P/E
|
0.0 | 95.35 | 13.75 |
|
5yr Avg Cash Conversion Cycle
|
205.44 Days | 29.1 Days | 97.95 Days |
|
Inventory Days
|
179.8 Days | 34.04 Days | 104.71 Days |
|
Days Receivable
|
44.97 Days | 55.38 Days | 36.37 Days |
|
Days Payable
|
33.13 Days | 55.7 Days | 24.63 Days |
|
5yr Average Interest Coverage Ratio
|
1.05 | -17.77 | 2.96 |
|
5yr Avg ROCE
|
11.82 % | -15.4 % | 24.39 % |
|
5yr Avg Operating Profit Margin
|
5.22 % | -16.49 % | 9.32 % |
|
5 yr average Debt to Equity
|
4.02 | 0.05 | 1.29 |
|
5yr CAGR Net Profit
|
18.77 % | 35.78 % | 73.13 % |
|
5yr Average Return on Assets
|
2.92 % | -13.36 % | 5.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.98 % | 53.33 % | 69.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -13.59 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Cosco India
|
Novelix Pharma
|
Silkflex Polymers
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|